Caption Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Caption Management’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-148,300	Closed	-$8.88M	–	1629
2021 Q1	$8.88M	Buy	148,300 +47,300	+47%	+$2.57M	0.19%	135
2020 Q4	$5.04M	Sell	101,000 -45,800	-31%	-$2.15M	0.11%	218
2020 Q3	$7.49M	Sell	146,800 -50,900	-26%	-$2.12M	0.18%	135
2020 Q2	$6.94M	Buy	+197,700	New	+$6.81M	0.23%	115

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Caption Management's AXNX Position: Q4 2021 in Review

Caption Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2021, closing a stake of 39,000 shares — an estimated $2.54M sold.

Caption Management first reported a position in AXNX in Q3 2021 and held it in 1 quarter. The position peaked at $2.54M in Q3 2021. 180 funds tracked by Wall St. Rank hold AXNX as of Q4 2021.

Caption Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Caption Management sold 39,000 Axonics, Inc. Common Stock shares in Q4 2021, an estimated $2.54M.
Caption Management first reported a position in Axonics, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
Caption Management's Axonics, Inc. Common Stock position peaked at $2.54M in Q3 2021.
180 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2021.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.